cefoxitin has been researched along with Sexually-Transmitted-Diseases* in 2 studies
1 trial(s) available for cefoxitin and Sexually-Transmitted-Diseases
| Article | Year |
|---|---|
Recurrent PID, subsequent STI, and reproductive health outcomes: findings from the PID evaluation and clinical health (PEACH) study.
PEACH trial data were used to evaluate the relationship between subsequent sexually transmitted infection and recurrent pelvic inflammatory disease on infertility and chronic pelvic pain (CPP). Recurrent pelvic inflammatory disease was associated with an almost 2-fold increase in infertility and more than 4-fold increase in CPP. Subsequent sexually transmitted infection was associated with CPP, but not infertility. Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefoxitin; Chronic Pain; Doxycycline; Female; Follow-Up Studies; Humans; Infertility, Female; Pelvic Inflammatory Disease; Pelvic Pain; Pregnancy; Pregnancy Complications; Probenecid; Recurrence; Reproductive Health; Sexually Transmitted Diseases; Treatment Outcome; United States; Uricosuric Agents; Young Adult | 2011 |
1 other study(ies) available for cefoxitin and Sexually-Transmitted-Diseases
| Article | Year |
|---|---|
National guideline for the management of pelvic infection and perihepatitis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Anti-Bacterial Agents; Cefoxitin; Ceftriaxone; Ciprofloxacin; Clindamycin; Contact Tracing; Female; Genital Diseases, Male; Humans; Male; Ofloxacin; Pelvic Inflammatory Disease; Peritonitis; Pregnancy; Pregnancy Complications, Infectious; Sexually Transmitted Diseases | 1999 |